Grant: MASSACHUSETTS GENERAL HOSPITAL, THE
Primary Recipient
MASSACHUSETTS GENERAL HOSPITAL, THE
Amount
$3,723,748.00
Award Date
9/27/2010
Administering Agency
Health and Human Services, Department of / National Institutes of Health
CDFA Number
93.701
CDFA Program Title
Trans-NIH Recovery Act Research Support
Description
Applying Genomics and Other High Throughput Technologies is the thematic area that this application addresses. Ovarian cancer is the most lethal gynecologic malignancy. It has a high response rate to initial combined platinum taxane chemotherapy following
Recipients Connected to Award
Recipient | Role | Amount |
---|---|---|
DANA-FARBER CANCER INSTITUTE, INC. | Sub-recipient | $1,882,172.00 |
UNIVERSITY OF TEXAS M D ANDERSON | Sub-recipient | $962,322.00 |
MASSACHUSETTS GENERAL HOSPITAL, THE | Primary recipient | $879,254.00 |